Your browser doesn't support javascript.
loading
Mepolizumab failed to affect bullous pemphigoid: A randomized, placebo-controlled, double-blind phase 2 pilot study.
Simon, Dagmar; Yousefi, Shida; Cazzaniga, Simone; Bürgler, Christina; Radonjic, Susanne; Houriet, Carine; Heidemeyer, Kristine; Klötgen, Hans-Wilhelm; Kozlowski, Evelyne; Borradori, Luca; Simon, Hans-Uwe.
Afiliación
  • Simon D; Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Yousefi S; Institute of Pharmacology, University of Bern, Bern, Switzerland.
  • Cazzaniga S; Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Bürgler C; Centro Studi GISED, Bergamo, Italy.
  • Radonjic S; Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Houriet C; Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Heidemeyer K; Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Klötgen HW; Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Kozlowski E; Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Borradori L; Institute of Pharmacology, University of Bern, Bern, Switzerland.
  • Simon HU; Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Allergy ; 75(3): 669-672, 2020 03.
Article en En | MEDLINE | ID: mdl-31230371

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Penfigoide Ampolloso Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Allergy Año: 2020 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Penfigoide Ampolloso Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Allergy Año: 2020 Tipo del documento: Article País de afiliación: Suiza